The company has aggressively deleveraged, reducing its debt-to-equity ratio from 0.38 in 2025Q4 to 0.03 in 2026Q1, though this is tempered by a substantial $45.3 million goodwill balance representing over 20% of total assets.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Jun'02 | Jun'01 | Jun'00 | Jun'99 | Jun'98 | Jun'97 | Jun'96 |
|---|
| Total Current Assets | 110.1M | 105.8M | 97.16M | 90.2M | 78.99M | 66.52M | 64.5M | 70.37M | 67.22M | 61.92M | 49.51M | 51.95M | 56.83M | 58.81M | 63.82M | 64.23M | 75.65M | 75.96M | 75.17M | 68.29M | 55.88M | 39.36M | 40.18M | 32.56M | 13.75M | 13.99M | 21.31M | 29.4M | 38.5M | 25.2M | 36.8M |
| Cash & Short-Term Investments | 8.89M | 9.35M | 6.85M | 10.28M | 5.71M | 8.41M | 10.65M | 7.41M | 25.93M | 18.33M | 10.71M | 14.53M | 17.87M | 16.49M | 10.08M | 5.49M | 5.11M | 6.09M | 1.88M | 2.25M | 720K | 3.21M | 11.53M | 830K | 2.02M | 1.67M | 10.99M | 17.9M | 2.4M | 2.8M | 1.2M |
| Cash Only | 8.89M | 9.35M | 6.85M | 10.28M | 5.71M | 8.41M | 10.65M | 7.41M | 25.93M | 18.33M | 10.71M | 14.53M | 17.87M | 16.49M | 10.08M | 5.49M | 5.11M | 6.09M | 1.88M | 2.25M | 720K | 3.21M | 10.53M | 830K | 2.02M | 706K | 1.37M | 2.2M | 2.4M | 2.8M | 1.2M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 0 | 2K | 968K | 9.62M | 15.7M | 0 | 0 | 0 |
| Accounts Receivable | 34.43M | 33.95M | 29.37M | 31.76M | 27.78M | 20.23M | 21.05M | 30.11M | 16.02M | 14.66M | 13.18M | 11.61M | 11.48M | 14.42M | 21.64M | 21.85M | 34.27M | 32.45M | 30.59M | 26.54M | 24.2M | 10.96M | 8.59M | 20.15M | 6.05M | 4.43M | 3.38M | 3.1M | 3.1M | 5.1M | 2.7M |
| Days Sales Outstanding | 63.94 | 64.82 | 65.18 | 73.07 | 76.91 | 75.15 | 71.34 | 102.9 | 67.04 | 62.55 | 58.34 | 55.43 | 63.01 | 66.78 | 77.68 | 57.22 | 70.05 | 68.82 | 43.83 | 70.4 | 94.41 | 56.77 | 31.92 | 92.58 | 67.9 | 66.86 | 50.3 | 53.63 | 68.99 | 117.08 | 65.26 |
| Inventory | 57.29M | 54.01M | 51.36M | 42.22M | 41.19M | 33.19M | 28.19M | 29.76M | 22.84M | 26.33M | 23.46M | 23.81M | 26.09M | 26.05M | 30.37M | 34.97M | 33.12M | 35.5M | 40.47M | 35.1M | 27.36M | 19.45M | 13.94M | 10.21M | 4.63M | 5.46M | 5.44M | 6.8M | 4.1M | 3.5M | 8.4M |
| Days Inventory Outstanding | 134.27 | 134.42 | 153.49 | 129 | 146.77 | 164.54 | 131 | 143.62 | 135.34 | 162.04 | 149.28 | 163.66 | 201.96 | 169.16 | 152 | 122.73 | 91.58 | 95.81 | 74.69 | 117.72 | 131.22 | 121.87 | 65.32 | 59.76 | 54.26 | 71.94 | 84.56 | 147.74 | 114.24 | 92.57 | 245.28 |
| Other Current Assets | 9.5M | 8.5M | 0 | 0 | 4.3M | 4.69M | 1.59M | 0 | 0 | 89K | 77K | 409K | 445K | 700K | 1.71M | 327K | 672K | 288K | 441K | 461K | 855K | 2.99M | 4.28M | 50K | 1.05M | 1.3M | 1.51M | 1.6M | 28.9M | 13.8M | 22.3M |
| Total Non-Current Assets | 110.53M | 111.11M | 123.29M | 88.07M | 89.44M | 93.01M | 73.2M | 74.18M | 52.88M | 35.27M | 35.23M | 29.62M | 30.79M | 31.41M | 33.9M | 36.58M | 39.18M | 55.21M | 54.41M | 53.76M | 41.88M | 41.4M | 40.95M | 19.8M | 16.32M | 32.25M | 34.92M | 35.9M | 32.1M | 24.7M | 23.8M |
| Property, Plant & Equipment | 40.12M | 40.4M | 44.64M | 24.71M | 23.9M | 25.79M | 22.85M | 22.52M | 10.74M | 7.57M | 8M | 9.04M | 9.81M | 10.2M | 12.41M | 12.59M | 14.48M | 16.65M | 18.46M | 19.36M | 19.4M | 19.93M | 20.2M | 18.21M | 16.13M | 32.02M | 33.84M | 32.5M | 31.4M | 24.1M | 10.7M |
| Fixed Asset Turnover | 4.45x | 4.73x | 3.68x | 6.42x | 5.52x | 3.81x | 4.71x | 4.74x | 8.12x | 11.30x | 10.31x | 8.46x | 6.78x | 7.73x | 8.19x | 11.07x | 12.33x | 10.34x | 13.79x | 7.11x | 4.82x | 3.54x | 4.86x | 4.36x | 2.02x | 0.75x | 0.72x | 0.65x | 0.52x | 0.66x | 1.41x |
| Goodwill | 45.33M | 45.38M | 45.01M | 37.57M | 37.43M | 38.07M | 27.02M | 26.75M | 20.11M | 20.46M | 19.96M | 16.28M | 16.41M | 16.42M | 16.34M | 18.36M | 18.28M | 25.44M | 22.94M | 21.18M | 13.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 10.65M | 10.93M | 24.56M | 15.11M | 15.92M | 17.39M | 9.21M | 9.72M | 6.5M | 7.08M | 7.19M | 3.95M | 4.34M | 4.65M | 5.04M | 5.53M | 6.15M | 13.06M | 12.93M | 13.11M | 9.07M | 0 | 0 | 0 | 183K | 233K | 332K | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -82K | -157K | -166K | -401K | -341K | -360K | -218K | -266K | -478K | -348K | -441K | -309K | -75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.67M | 3.91M | 9.09M | 122K | 121K | 298K | 2.29M | 1.96M | 82K | 125K | 72K | 309K | 235K | 269K | 98K | 105K | 270K | 60K | 81K | 97K | 66K | 18.96M | 17.67M | 1.58M | 0 | 0 | 749K | 3.4M | 700K | 600K | 13.1M |
| Total Assets | 220.63M | 216.91M | 220.45M | 178.28M | 168.43M | 159.54M | 137.7M | 144.56M | 120.1M | 97.19M | 84.74M | 81.57M | 87.62M | 90.22M | 97.72M | 100.81M | 114.83M | 131.17M | 129.59M | 122.05M | 97.76M | 80.76M | 81.13M | 52.35M | 30.06M | 46.24M | 56.23M | 65.3M | 70.6M | 49.9M | 60.6M |
| Asset Turnover | 0.85x | 0.88x | 0.75x | 0.89x | 0.78x | 0.62x | 0.78x | 0.74x | 0.73x | 0.88x | 0.97x | 0.94x | 0.76x | 0.87x | 1.04x | 1.38x | 1.56x | 1.31x | 1.97x | 1.13x | 0.96x | 0.87x | 1.21x | 1.52x | 1.08x | 0.52x | 0.44x | 0.32x | 0.23x | 0.32x | 0.25x |
| Asset Growth % | 56% | -1.61% | 23.66% | 5.85% | 5.57% | 15.86% | -4.74% | 20.36% | 23.58% | 14.68% | 3.89% | -6.91% | -2.88% | -7.68% | -3.07% | -12.21% | -12.45% | 1.22% | 6.18% | 24.85% | 21.05% | -0.46% | 54.98% | 74.14% | -34.99% | -17.76% | -13.89% | -7.51% | 41.48% | -17.66% | -3.19% |
| Total Current Liabilities | 43.05M | 37.33M | 29.29M | 23.73M | 28.91M | 18.92M | 18.71M | 17.19M | 14.95M | 14.24M | 11.33M | 10.86M | 11.19M | 12.02M | 19.9M | 23.16M | 36.34M | 48.13M | 32.24M | 41.83M | 37.81M | 18.38M | 9.54M | 17.85M | 8.8M | 7.09M | 7.04M | 5.8M | 5.9M | 6.4M | 4.2M |
| Accounts Payable | 24.06M | 17.42M | 14.16M | 11.34M | 16.07M | 9.82M | 10.84M | 9.39M | 9.92M | 8.79M | 7.29M | 6.49M | 7M | 7.05M | 11.36M | 13.77M | 16.34M | 19.18M | 20.25M | 18.33M | 15.93M | 5.22M | 3.54M | 6.38M | 3.09M | 4.37M | 3.3M | 3M | 3.9M | 3.8M | 2.7M |
| Days Payables Outstanding | 44.22 | 43.36 | 42.31 | 34.64 | 57.27 | 48.7 | 50.36 | 45.31 | 58.77 | 54.09 | 46.41 | 44.63 | 54.16 | 45.8 | 56.84 | 48.32 | 45.17 | 51.75 | 37.38 | 61.47 | 76.38 | 32.7 | 16.61 | 37.38 | 36.2 | 57.56 | 51.3 | 65.18 | 108.66 | 100.51 | 78.84 |
| Short-Term Debt | 3.44M | 4.13M | 2.75M | 2M | 2.9M | 2.87M | 1.36M | 1.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.72M | 19.08M | 1.43M | 13.42M | 12.25M | 7.71M | 2.39M | 8.29M | 3.15M | 955K | 1.15M | 200K | 100K | 0 | 0 |
| Deferred Revenue (Current) | 298K | 0 | 0 | 0 | 119K | 0 | 0 | 0 | -439K | 0 | 0 | 0 | 0 | 0 | 1.85M | 1.79M | 2.89M | 3.34M | 4.53M | 1.9M | 0 | 940K | 885K | 821K | 694K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 15.56M | 15.79M | 298K | 287K | 6.93M | 4.39M | 0 | 0 | -121K | 168K | 172K | 227K | 69K | 103K | 4.63M | 6.01M | -2.75M | 4.27M | 3.9M | 8.18M | 8.34M | 4.51M | 2.72M | 2.35M | 1.86M | 1.76M | 2.59M | 2.6M | 1.9M | 2.6M | 1.5M |
| Current Ratio | 2.56x | 2.83x | 3.32x | 3.80x | 2.73x | 3.52x | 3.45x | 4.09x | 4.50x | 4.35x | 4.37x | 4.78x | 5.08x | 4.89x | 3.21x | 2.77x | 2.08x | 1.58x | 2.33x | 1.63x | 1.48x | 2.14x | 4.21x | 1.82x | 1.56x | 1.97x | 3.02x | 5.07x | 6.53x | 3.94x | 8.76x |
| Quick Ratio | 1.23x | 1.39x | 1.56x | 2.02x | 1.31x | 1.76x | 1.94x | 2.36x | 2.97x | 2.50x | 2.30x | 2.59x | 2.75x | 2.72x | 1.68x | 1.26x | 1.17x | 0.84x | 1.08x | 0.79x | 0.75x | 1.08x | 2.75x | 1.25x | 1.04x | 1.20x | 2.25x | 3.90x | 5.83x | 3.39x | 6.76x |
| Cash Conversion Cycle | 153.99 | 155.87 | 176.36 | 167.43 | 166.4 | 190.99 | 151.98 | 201.21 | 143.61 | 170.5 | 161.21 | 174.46 | 210.81 | 190.15 | 172.84 | 131.64 | 116.45 | 112.88 | 81.14 | 126.66 | 149.26 | 145.93 | 80.62 | 114.97 | 85.96 | 81.24 | 83.56 | 136.19 | 74.57 | 109.14 | 231.7 |
| Total Non-Current Liabilities | 47.83M | 49.45M | 56.97M | 29.12M | 23.11M | 22.87M | 2.07M | 17.62M | 623K | 3.9M | 5.56M | 4.65M | 4.52M | 4.55M | 4.37M | 4.43M | 4.7M | 4.92M | 9.2M | 17.21M | 20.36M | 267K | 7.97M | 68K | 103K | 2.2M | 3.12M | 400K | 100K | 100K | 3.4M |
| Long-Term Debt | 0 | 45.53M | 51.5M | 23.62M | 19.31M | 18.86M | 0 | 15.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 251K | 267K | 4.67M | 16.22M | 20.04M | 25K | 7.21M | 68K | 103K | 2.2M | 3.12M | 500K | 100K | 0 | 0 |
| Capital Lease Obligations | 5.07M | 0 | 3M | 2.64M | 1.31M | 1.74M | 1.52M | 1.25M | 376K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200K | 0 | 0 | 0 | 25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 3.33M | 1M | 0 | 1.71M | 1.92M | 2.25M | 515K | 559K | 623K | 3.9M | 5.56M | 4.65M | 4.52M | 4.24M | 4.16M | 4.17M | 3.91M | 4.1M | 3.89M | 0 | 0 | 21.22M | 20.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 46.87M | 2.92M | 2.47M | 1.14M | 17K | 17K | 1.56M | -528K | -344K | 0 | 18K | 28K | 56K | 283K | 210K | 261K | 538K | 351K | 634K | 985K | 316K | 217K | 756K | 0 | 0 | 0 | 0 | -100K | 0 | 100K | 0 |
| Total Liabilities | 90.89M | 86.78M | 86.26M | 52.85M | 52.03M | 41.8M | 20.78M | 34.81M | 15.57M | 18.14M | 16.88M | 15.51M | 15.71M | 16.57M | 24.27M | 27.59M | 41.04M | 53.05M | 41.43M | 59.04M | 58.17M | 18.65M | 17.51M | 17.92M | 8.9M | 9.29M | 10.16M | 6.2M | 6M | 6.5M | 4.2M |
| Total Debt | 3.44M | 49.65M | 58.39M | 29.16M | 23.51M | 23.47M | 3.56M | 19.02M | 815K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.97M | 19.35M | 6.09M | 29.65M | 32.29M | 7.74M | 9.61M | 8.36M | 3.25M | 3.16M | 4.27M | 700K | 200K | 0 | 0 |
| Net Debt | -5.45M | 40.31M | 51.53M | 18.88M | 17.8M | 15.05M | -7.09M | 11.61M | -25.12M | -18.33M | -10.71M | -14.53M | -17.87M | -16.49M | -10.08M | -5.49M | 3.86M | 13.26M | 4.22M | 27.4M | 31.57M | 4.53M | -924K | 7.53M | 1.24M | 2.45M | 2.9M | -1.5M | -2.2M | -2.8M | -1.2M |
| Debt / Equity | 0.03x | 0.38x | 0.44x | 0.23x | 0.20x | 0.20x | 0.03x | 0.17x | 0.01x | - | - | - | - | - | - | - | 0.12x | 0.25x | 0.07x | 0.47x | 0.82x | 0.12x | 0.15x | 0.24x | 0.15x | 0.09x | 0.09x | 0.01x | 0.00x | - | - |
| Debt / EBITDA | 0.37x | 3.37x | 4.13x | 2.18x | 5.12x | 6.57x | 0.41x | 1.88x | 0.09x | - | - | - | - | - | - | - | - | - | 0.26x | 4.96x | 16.91x | 27.74x | 1.14x | 0.92x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.59x | 2.74x | 3.65x | 1.41x | 3.88x | 4.21x | -0.82x | 1.15x | -2.81x | -2.06x | -1.65x | -4.08x | - | - | -26.31x | -0.81x | - | - | 0.18x | 4.58x | 16.54x | 16.22x | -0.11x | 0.83x | - | - | - | - | - | - | - |
| Interest Coverage | 1.02x | 2.33x | 5.28x | 5.52x | 0.53x | 0.38x | 17.11x | 13.56x | 104.05x | 35.39x | 15.44x | 14.03x | -7.27x | -2.57x | -0.30x | 4.74x | 10.25x | -4.92x | 19.10x | - | -10.06x | -2.28x | 0.56x | - | -1353.03x | -10.98x | - | - | -2.86x | - | - |
| Total Equity | 129.75M | 130.13M | 134.19M | 125.43M | 116.4M | 117.74M | 116.92M | 109.75M | 104.53M | 79.05M | 67.86M | 66.06M | 71.91M | 73.64M | 73.45M | 73.23M | 73.8M | 78.11M | 88.15M | 63.01M | 39.59M | 62.11M | 63.63M | 34.43M | 21.16M | 36.95M | 46.07M | 59.1M | 64.6M | 43.4M | 56.4M |
| Equity Growth % | -1.98% | -3.02% | 6.98% | 7.75% | -1.14% | 0.7% | 6.54% | 4.99% | 32.24% | 16.49% | 2.72% | -8.14% | -2.35% | 0.26% | 0.31% | -0.77% | -5.53% | -11.39% | 39.91% | 59.15% | -36.26% | -2.39% | 84.8% | 62.68% | -42.73% | -19.78% | -22.05% | -8.51% | 48.85% | -23.05% | -2.76% |
| Book Value per Share | 7.79 | 7.82 | 8.00 | 7.73 | 7.22 | 7.34 | 7.26 | 6.78 | 6.39 | 4.98 | 4.41 | 4.02 | 4.12 | 4.22 | 4.22 | 4.22 | 4.30 | 4.60 | 4.99 | 4.05 | 2.66 | 4.27 | 4.22 | 2.47 | 1.71 | 3.32 | 4.22 | 5.64 | 7.75 | 5.48 | 7.23 |
| Total Shareholders' Equity | 129.63M | 130M | 134M | 125.33M | 116.28M | 117.62M | 116.8M | 109.73M | 104.62M | 79.2M | 68.03M | 66.2M | 72.03M | 73.74M | 73.52M | 73.26M | 73.77M | 78.06M | 88.13M | 63.01M | 39.59M | 62.11M | 63.63M | 34.43M | 21.16M | 36.95M | 46.07M | 59.1M | 64.6M | 43.4M | 56.4M |
| Common Stock | 2.11M | 2.11M | 2.11M | 2.08M | 2.06M | 2.05M | 2.04M | 2.03M | 2M | 1.97M | 1.93M | 1.92M | 1.9M | 1.89M | 1.89M | 1.87M | 1.86M | 1.83M | 1.81M | 1.71M | 1.58M | 1.55M | 1.5M | 1.43M | 1.34M | 1.26M | 1.15M | 1.1M | 0 | 0 | 0 |
| Retained Earnings | -40.79M | -40.34M | -34.44M | -40.75M | -47.95M | -47.83M | -47.6M | -52.83M | -57.96M | -82.89M | -90.54M | -94.05M | -96.92M | -94.8M | -93.88M | -92.28M | -90.2M | -84.02M | -74.78M | -88.44M | -94.03M | -66.54M | -62.19M | -84.53M | -86.91M | -68.79M | -53.3M | -39.1M | -30.1M | -22.9M | -12.9M |
| Treasury Stock | 0 | -21.49M | -21.49M | -21.49M | -21.48M | -21.47M | -21.32M | -21.23M | -19.27M | -18.47M | -18.44M | -17.81M | -8.42M | -7.66M | -7.66M | -7.66M | -7.65M | -7.56M | -4.23M | -2.4M | -2.38M | -2.38M | -2.38M | -2.38M | 0 | -303K | -303K | -300K | 0 | 0 | 0 |
| Accumulated OCI | -3.06M | -3.14M | -4.01M | -3.66M | -3.75M | -1.65M | -1.78M | -2.53M | -2.79M | -1.61M | -3.08M | -863K | -467K | -614K | -620K | -985K | -1.26M | -1.26M | -1.93M | 69K | -321K | -1.05M | -605K | -723K | -856K | -835K | -864K | 600K | -4.7M | -3.1M | -1.9M |
| Minority Interest | 119K | 139K | 192K | 95K | 126K | 127K | 123K | 24K | -85K | -154K | -170K | -143K | -114K | -99K | -65K | -34K | 24K | 54K | 21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Working capital and margin volatility
According to the provided quarterly balance sheets, Ultralife's total assets have increased from $178.3 million in 2023Q4 to $220.6 million in 2026Q1, yet this expansion has not translated into equity growth, as retained earnings remain deeply negative at -$40.8 million, signaling a disconnect between asset accumulation and profitability.
The growth in the asset base appears to be driven by acquisition-related goodwill and increased property, plant, and equipment, rather than organic earnings retention. This trajectory suggests that management is prioritizing scale through inorganic means, which warrants caution given the lack of corresponding improvement in bottom-line performance.
Based on reported financial statements, Ultralife maintains a conservative capital structure with a debt-to-equity ratio of 0.03 as of 2026Q1, a significant reduction from the 0.38 observed in 2025Q4, indicating that the company has utilized its cash position to aggressively deleverage despite ongoing net losses.
The rapid reduction in debt suggests a strategic preference for balance sheet safety over financial leverage, likely to mitigate risks associated with the cyclical nature of defense contracting. While this low leverage provides a buffer against insolvency, it also highlights the company's limited reliance on external financing to fund its current operational deficits.
As reported in the quarterly filings, goodwill accounts for $45.3 million of the $220.6 million in total assets as of 2026Q1, representing a significant portion of the company's book value and suggesting that future asset quality is heavily dependent on the performance of past acquisitions.
The concentration of intangible assets relative to tangible property, plant, and equipment of $40.1 million implies that the company's valuation is sensitive to impairment risks if acquired business units fail to meet growth expectations. Investors should monitor whether these intangible assets continue to represent a growing share of the balance sheet, as this could indicate a reliance on acquisition-driven growth rather than internal innovation.
According to the latest balance sheet data, Ultralife maintains a current ratio of 2.56 as of 2026Q1, which, while lower than the 3.32 peak observed in 2024Q4, continues to provide a sufficient liquidity cushion to cover short-term obligations despite the company's recent negative net margin performance.
The company's ability to maintain a current ratio well above 2.0 suggests that it is not currently facing immediate liquidity constraints, even as cash balances have fluctuated. However, the reliance on current assets to support operations in the absence of consistent profitability warrants close monitoring of the cash conversion cycle and working capital efficiency.
Based on the company's reported figures, the persistent negative retained earnings balance of -$40.8 million as of 2026Q1 serves as a critical indicator that historical operational losses have eroded shareholder equity, potentially masking the true economic cost of the company's recent growth and acquisition strategy.
The fact that retained earnings have remained consistently negative over the last ten quarters suggests that the company has struggled to generate sustainable value for shareholders despite revenue growth. This structural deficit implies that the balance sheet's apparent health is supported more by capital preservation than by the successful compounding of earnings, which may limit future capital allocation flexibility.
Quick answers to the most common questions about buying ULBI stock.
As of 2025, Ultralife Corporation (ULBI) had total assets of $216.9M including $105.8M in current assets.
Ultralife Corporation (ULBI) carries total debt of $49.7M, offset by $9.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Ultralife Corporation (ULBI) has total shareholders' equity (book value) of $130.0M ($7.82 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Ultralife Corporation (ULBI) reported a current ratio of 2.83x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.